Modulation of cat antral slow waves by ion substitution, Ca2+ and K+ channel blockade, and ACh stimulation.
Two distinct slow waves can be recorded from smooth muscle cells on the submucosal border (submucosal cells) and the myenteric border (myenteric cells) in the circular layer of the cat antrum. The present studies examined the effects of decreasing extracellular Na+ ([Na+]o) or Ca2+ concentration ([Ca2+]o), Ca2+ and K+ channel blockade, and acetylcholine (ACh) stimulation on "submucosal" and "myenteric" slow waves using intracellular recording techniques. Decreasing [Na+]o (30 mM) reduced the upstroke depolarization of slow waves from submucosal cells but had no effect on the upstroke depolarization of myenteric cells. Decreasing [Ca2+]o (0.5 mM) decreased the upstroke depolarization in cells from each area. Neither cadmium (200 microM) nor nifedipine (100 microM) had any effect on the upstroke depolarizations from both submucosal and myenteric slow waves. In contrast, nickel (5 mM), a nonselective Ca2+ channel blocker, decreased the upstroke depolarizations of slow waves from submucosal and myenteric cells. Slow waves from myenteric cells normally exhibit a plateau phase of several seconds duration. The amplitude of the plateau potential could be decreased by lowering [Na+]o or [Ca2+]o or by nickel, cadmium or nifedipine. In the presence of 30 mM Na+ slow waves from submucosal cells appeared to develop plateau potentials. K+ channel blockade with tetrabutylammonium (TBA, 5 mM) or cesium (10 mM) increased the upstroke depolarization and delayed membrane repolarization in slow waves from submucosal cells. TBA and cesium also increased the upstroke depolarization from myenteric cells but did not delay membrane repolarization. ACh (1 and 3 microM) caused the generation of plateau potentials in slow waves from submucosal cells and increased slow-wave duration.(ABSTRACT TRUNCATED AT 250 WORDS)
Renzetti
L M
LM
Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Wang
M B
MB
Ryan
J P
JP
D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002415:Cats; D002586:Cesium / Q000494:pharmacology; D004594:Electrophysiology; D007477:Ions; D007552:Isotonic Solutions / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D011706:Pyloric Antrum / Q000187:drug effects / Q000502:physiology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology
D002121:Calcium Channel Blockers; D007477:Ions; D007552:Isotonic Solutions; C051865:Krebs-Ringer solution; D015221:Potassium Channels; D000644:Quaternary Ammonium Compounds; D002586:Cesium; D012964:Sodium; C009405:tetrabutylammonium; D000109:Acetylcholine; D002118:Calcium